Publications
- 2023年
- 2022年
- 2021年
- 2020年以前
- 受賞歴
- Patents
- Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cells
Riko Fujioka, Takeshi Yamamoto, Akihiro Maruta, Yoshihide Nakamura, Naoomi Tominaga, Masako Inamitsu, Tetsuro Oda, Shigeki Kobayashi, Masafumi Yano
Biochemical and Biophysical Research Communications. doi: 10.1016/j.bbrc.2023.02.038. PMID: 36812708
- 4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations
- Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
- Dantrolene reduces platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice
Kana Tominaga♰, Naoomi Tominaga♰, Eric O Williams, Laura Rufibach, Verena Schöwel, Simone Spuler, Mohan Viswanathan, Leonard P Guarente
♰These authors contributed equally
iScience. doi: 10.1016/j.isci.2021.103667. PMID: 35028538
Masafumi Yano Mei Mikawa, Chihiro Sakai, Takeshi Yamamoto, Yoshihide Nakamura, Shinji Tanaka, Naoomi Tominaga, Masako Inamitsu, Tetsuro Oda, Shigeki Kobayashi
Biochemistry and biophysics reports.. doi: 10.1016/j.bbrep.2022.101248. PMID: 35313646
Chihiro Sakai, Mei Mikawa, Takeshi Yamamoto, Tomoyuki Uchida, Yoshihide Nakamura, Hideaki Akase, Takeshi Suetomi, Naoomi Tominaga, Masako Inamitsu, Tetsuro Oda, Takayuki Okamura, Shigeki Kobayashi, Masafumi Yano
Biochemical and biophysical research communications.. doi: 10.1016/j.bbrc.2022.07.038. PMID: 35872542
- Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles
Naoomi Tominaga
Cancers. doi: 10.3390/cancers13246303. PMID: 34944923
- Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake
- Contribution of Extracellular Vesicles to Cancer Initiation through Cellular Senescence during Aging
- Indispensable roles of glycosylated extracellular vesicles for cancer cell metastasis
- Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis
- A novel platform for cancer therapy using extracellular vesicles
- Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier
- Micromanaging of tumor metastasis by extracellular vesicles
- RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy
- Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
- Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy
- Trash or Treasure: extracellular microRNAs and cell-to-cell communication
- Functional analysis of exosomal microRNA in cell–cell communication research
- Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy
- 70-Gene classifier for differentiation between paclitaxel-and docetaxel-sensitive breast cancers
- Prediction of pathologic complete response to sequential paclitaxel and 5‐fluorouracil/epirubicin/cyclophosphamide therapy using a 70‐gene classifier for breast cancers
- Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
- High genomic grade index associated with poor prognosis for lymph node‐negative and estrogen receptor‐positive breast cancers and with good response to chemotherapy
Nao Nishida-Aoki, Naoomi Tominaga, Nobuyoshi Kosaka, Takahiro Ochiya
Journal of extracellular vesicles. doi: 10.1080/20013078.2020.1713527. PMID: 32082512
N Tominaga
Cancer Studies.
Nobuyoshi Kosaka, Nao Nishida-Aoki, Naoomi Tominaga, Yusuke Yoshioka, Takahiro Ochiya
CANCER SCIENCE.
Nao Nishida-Aoki, Naoomi Tominaga, Fumitaka Takeshita, Hikaru Sonoda, Yusuke Yoshioka, Takahiro Ochiya
Molecular Therapy. doi: 10.1016/j.ymthe.2016.10.009. PMID: 28129113
Naoomi Tominaga, Yusuke Yoshioka, Takahiro Ochiya
Advanced Drug Delivery Reviews. doi: 10.1016/j.addr.2015.10.002. PMID: 26482189
Nature communications. doi: 10.1038/ncomms7716. PMID: 25828099
Seminars in Cell & Developmental Biology. doi: 10.1016/j.semcdb.2015.02.016. PMID: 25746922
Naoomi Tominaga, Keitaro Hagiwara, Nobuyoshi Kosaka, Kimi Honma, Hitoshi Nakagama, Takahiro Ochiya
Molecular cancer. doi: 10.1186/1476-4598-13-134. PMID: 24884960
Makiko Ono, Nobuyoshi Kosaka, Naoomi Tominaga, Yusuke Yoshioka, Fumitaka Takeshita, Ryou-u Takahashi, Masayuki Yoshida, Hitoshi Tsuda, Kenji Tamura, Takahiro Ochiya
Science signaling. doi: 10.1126/scisignal.2005231. PMID: 24985346
Nobuyoshi Kosaka, Yusuke Yoshioka, Naoomi Tominaga, Keitaro Hagiwara, Takeshi Katsuda, Takahiro Ochiya
Future Oncology. doi: 10.2217/fon.13.222. PMID: 24754596
Nobuyoshi Kosaka, Yoshioka Yusuke, Keitaro Hagiwara, Naoomi Tominaga, Takeshi Katsuda, Takahiro Ochiya
Frontiers in genetics. doi: 10.3389/fgene.2013.00173. PMID: 24046777
Nobuyoshi Kosaka, Yusuke Yoshioka, Keitaro Hagiwara, Naoomi Tominaga, Takahiro Ochiya
Circulating MicroRNAs. doi: 10.1007/978-1-62703-453-1_1. PMID: 23719938
N Tominaga, Y Naoi, K Shimazu, T Nakayama, N Maruyama, A Shimomura, SJ Kim, Y Tamaki, S Noguchi
Annals of oncology. doi: 10.1093/annonc/mds120. PMID: 22767585
Y Naoi, T Tanei, K Kishi, R Tsunashima, N Tominaga, Y Baba, T Nakayama, K Shimazu, SJ Kim, Y Tamaki, S Noguchi
Cancer letters. doi: 10.1016/j.canlet.2011.09.032. PMID: 22018777
Yasuto Naoi, Kazuki Kishi, Tomonori Tanei, Ryo Tsunashima, Naoomi Tominaga, Yosuke Baba, Seung Jin Kim, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
Cancer. doi: 10.1002/cncr.25953. PMID: 21305539
Yasuto Naoi, Kazuki Kishi, Tomonori Tanei, Ryo Tsunashima, Naoomi Tominaga, Yosuke Baba, Seung Jin Kim, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
Breast cancer research and treatment. doi: 10.1007/s10549-010-1145-z. PMID: 20803240
Yasuto Naoi, Kazuki Kishi, Tomonori Tanei, Ryo Tsunashima, Naoomi Tominaga, Yosuke Baba, Seung Jin Kim, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
Cancer. doi: 10.1002/cncr.25626. PMID: 20878674
- 革新的研究の発掘と育成(FOCS)プロジェクト研究奨励賞受賞
2023年度FOCSプロジェクト研究奨励賞を受賞いたしました。
- Method for suppressing brain metastasis
- Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier
- Compositions and methods for treating dysferlinopathy
Takahiro Ochiya, Naoomi Tominaga
US Patent App. 16/745,967
Takahiro Ochiya, Naoomi Tominaga
US Patent 10,544,466
Leonard P. Guarente, Kana TOMINAGA, Naoomi TOMINAGA, Mohan VISWANATHAN, Eric WILLAMS
WO2023278684A1